Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study-Reference-Cited by-同舟云学术

Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study

Published:2024-06-16 Issue:8 Volume:41 Page:3119-3137
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Kim Hae Jin,Hur Kyu Yeon,Lee Yong-Ho,Kim Jin Taek,Lee Yong-Kyu,Baek Ki-Hyun,Choi Euy Jin,Hwang Won Min,Bang Ki Tae,Lim Jung Soo,Chung Yun Jae,Jo Sung Rae,Oh Joon Seok,Lee Soon Hee,Ko Seung-Hyun,Choi Sung Hee^ORCID

Funder

Daiichisankyo, Korea

Seoul National University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12325-024-02862-5.pdf

Reference36 articles.

1. Mach F, Baigent C, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41:111–88. https://doi.org/10.1093/eurheartj/ehz455

2. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–337. https://doi.org/10.1093/eurheartj/ehab484.

3. Su X, Zhang L, Lv J, et al. Effect of statins on kidney disease outcomes: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67:881–92. https://doi.org/10.1053/j.ajkd.2016.01.016.

4. Hou W, Lv J, Perkovic V, et al. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J. 2013;34:1807–17. https://doi.org/10.1093/eurheartj/eht065.

5. Cholesterol Treatment Trialists’ (CTT) Collaboration, Herrington WG, Emberson J, et al. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes Endocrinol. 2016;4:829–39. https://doi.org/10.1016/S2213-8587(16)30156-5.